Gregory T. Went

2016

In 2016, Gregory T. Went earned a total compensation of $2.6M as Chief Executive Officer at Adamas Pharmaceuticals, a 61% increase compared to previous year.

Compensation breakdown

Bonus$250,000
Option Awards$1,476,617
Salary$450,000
Stock Awards$392,725
Other$690
Total$2,570,032

Went received $1.5M in option awards, accounting for 57% of the total pay in 2016.

Went also received $250K in bonus, $450K in salary, $392.7K in stock awards and $690 in other compensation.

Rankings

In 2016, Gregory T. Went's compensation ranked 3,815th out of 14,075 executives tracked by ExecPay. In other words, Went earned more than 72.9% of executives.

ClassificationRankingPercentile
All
3,815
out of 14,075
73rd
Division
Manufacturing
1,326
out of 5,486
76th
Major group
Chemicals And Allied Products
408
out of 1,900
79th
Industry group
Drugs
299
out of 1,543
81st
Industry
Pharmaceutical Preparations
234
out of 1,173
80th
Source: SEC filing on April 18, 2017.

Went's colleagues

We found two more compensation records of executives who worked with Gregory T. Went at Adamas Pharmaceuticals in 2016.

2016

Jennifer Rhodes

Adamas Pharmaceuticals

General Counsel

2016

Rajiv Patni

Adamas Pharmaceuticals

Chief Medical Officer

News

In-depth

You may also like